TTDDDP founded a partnership with GCC, a research consortium organized in 2001 to bring together scientists interested in this area of research with the motivation of developing an inter-institutional academic drug discovery program. With the desire to maximize screening capabilities while minimizing duplication of effort and resources, the GCC has supported Gulf Coast investigators with an integrated capability to perform high throughput screening projects (GCC-CG). Currently GCC-CG has 7 participating institutions including UT-Austin, Baylor College of Medicine (BCM), Rice University (Rice), (University of Houston (UH), University of Texas Health Science Center at Houston (UTHSC-H), University of Texas Medical branch at Galveston (UTMB-G), and University of Texas at M.D. Anderson Cancer Center (UTMDACC). As a member of GCC-CG, the core users could have access to use of GCC-CG facilities located at GCC-CG member institutions at regular (or internal) rates. This partnership benefited UT-Austin scientists with facile access to more complicated screening such as cell-based image and siRNA in addition to vigorous collaborations across the State of Texas. Learn more…